Atlas Trials

Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment

Clinical trial NCT04820621 · TERMINATED

Trial details

NCT number
NCT04820621
Sponsor
Bayer
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2021-04-07
Primary completion
2021-07-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.